SCHEMBL14079811

SCHEMBL14079811

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5c6ccccc6c(-c6ccccc6)c6ccccc56)cc4)nc(-c4ccc(-c5c6ccccc6c(-c6ccccc6)c6ccccc56)cc4)n3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.52
▸ MEN1 O00255 6/20 0.50
▸ KMT2A Q03164 6/20 0.50
▸ ATM Q13315 1/20 0.50
▸ MAPT P10636 3/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ POLB P06746 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ ADORA2A P29274 1/20 0.46
▸ ADORA2B P29275 1/20 0.46
▸ ADORA1 P30542 1/20 0.46
▸ ESR1 P03372 2/20 0.46
▸ ESR2 Q92731 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ NTSR1 P30989 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18632806 1.00 L3MBTL1 (0.52) L3MBTL1MEN1KMT2AATMMAPT
SCHEMBL18878267 1.00 L3MBTL1 (0.52) L3MBTL1MEN1KMT2AATMMAPT
SCHEMBL22766471 1.00 L3MBTL1 (0.52) L3MBTL1MEN1KMT2AATMMAPT
SCHEMBL18878257 1.00 L3MBTL1 (0.52) L3MBTL1MEN1KMT2AATMMAPT
SCHEMBL13871679 0.98 L3MBTL1 (0.54) L3MBTL1MEN1KMT2AATMMAPT
SCHEMBL22547229 0.98 L3MBTL1 (0.54) L3MBTL1MEN1KMT2AATMMAPT
SCHEMBL14079812 0.98 L3MBTL1 (0.54) L3MBTL1MEN1KMT2AATMMAPT
SCHEMBL22766706 0.96 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AATMMAPT
SCHEMBL22544967 0.96 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AATMMAPT
SCHEMBL22766701 0.96 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AATMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080199726-A1 Electroluminescent Device CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2008-08-21 — — US disclosed
US-20080199726-A1 Electroluminescent Device CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2008-08-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080199726-A1 Electroluminescent Device TPMT, THPO, KYNU L3MBTL1 1449/4885MEN1 1856/4885KMT2A 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback